Basic Information
BioChemics Transdermal Drug Delivery Technology Aims to Provide Treatment for the SkinThe developer of BioChemics transdermal drug delivery technology aims to provide treatment for the skin. The company's technology delivers products that can penetrate various active pharmaceutical molecules deep into skin tissue or blood. Through small-dose drugs directly targeting specific areas, it eliminates the need for large oral doses, thereby avoiding additional side effects and enabling patients to receive advanced care for skin issues.
BioChemics,Inc.
Denver,Colorado,United States of America
15~50 people
January 01, 1989
biochem@t-online.de

